Recent news on Interferon

Biolex Raises $30M In Series C To Advance Hepatitis C Drug  -  25 May 2007
BioWorld Online,Awaiting data from an ongoing Phase II trial of Locteron, a controlled-release interferon-alpha candidate for hepatitis C, Biolex Therapeutics Inc. closed a

Low Levels of Common Enzyme Key to Resistance in Ewing’s Sarcoma  -  25 May 2007
PressZoom (press release),However, the addition of interferon-gamma, a protein produced by cells of the immune system, to treatment with TRAIL caused the resistant cells to produce

Migden's travails put spotlight on advances in cancer drugs  -  25 May 2007
Marin Independent-Journal,Before that she tried unsuccessfully three other types of treatment: Hydroxyurea, interferon and homoharringtonine, which is made from the bark of a tree in

Scientists’ studies combat health threats  -  25 May 2007
Arizona State University,In a paper published in the March issue of the Journal of Virology, titled “Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon

p150/95 (CD11c/CD18) Expression Is Required for the Development of ...  -  25 May 2007
Am J Pathology (subscription)EAE in CD11c –/– mice was significantly attenuated and characterized by markedly reduced spinal cord T-cell infiltration and interferon- production by these

MedImmune Highlights Advances in Inflammatory Disease Pipeline ...  -  25 May 2007
PR Newswire (press release),Genomic-based high throughput screening and identification of small molecule inhibitors targeting interferon-alpha signaling pathways," J. Immunol.,

Hepatitis B Patients Understanding Of Infection And Treatment ...  -  25 May 2007
eMaxHealth.com,Of those, 24 percent were on interferon treatment. Most of these patients were males between the ages of 31 and 50, with about half being of Asian descent.

Hep B Patients' Understanding of the Disease is Deficient  -  25 May 2007
Newswise (press release)Of those, 24 percent were on interferon treatment. Most of these patients were males between the ages of 31 and 50, with about half being of Asian descent.

International panel issues new HIV/HCV co-infection guidelines  -  May 24, 2007
Aidsmap,Higher doses of pegylated interferon have been studied in co-infected patients, but so far results are inconclusive. Therefore, the panel recommended the

Low Levels of Common Enzyme Key to Resistance in Ewing's Sarcoma  -  May 23, 2007
PharmaLive.com (press release),However, the addition of interferon-gamma, a protein produced by cells of the immune system, to treatment with TRAIL caused the resistant cells to produce

Final Results From Phase 2 Combination Study For Treatment Of ...  -  May 22, 2007
eMaxHealth.com,Intarcia Therapeutics presents results from a Phase 2 study comparing the combination of injectable omega interferon and ribavirin to omega interferon alone

Intarcia Therapeutics Announces Presentation of Final Results from ...  -  May 22, 2007
PipelineReview.com (press release),This Phase 2 study of daily subcutaneous omega interferon injections provides Intarcia with safety and clinical response data to support development of

A cure for Hepatitis C using existing treatments  -  May 23, 2007
News-Medical.net,The current standard therapy uses pegylated interferon and ribavirin which are known to work initially, but it had been unclear whether the virus could

Nautilus Biotech Receives FDA Approval for Phase 1 Clinical Trial ...  -  May 21, 2007
PR Newswire (press release),This is an important milestone in the development of treatments for a range of therapeutic diseases - all currently marketed Interferon-alpha drugs are

Hepatitis C ‘Cures’ Now Common  -  May 22, 2007
FOX NewsThose treatments include a long-acting version of the drug interferon, known as pegylated interferon, and the antiviral drug ribavirin.

Surviving Hepatitis C — Do You Harbor this Silent Killer?  -  May 21, 2007
Blogger News NetworkIn 1995, despite country singer Naomi Judd’s success with Interferon for her Hepatitis C, for many, it meant terrible side effects, but no eradication of

Hepatitis C drugs provide ‘cure’  -  May 22, 2007
The News - International,Standard therapy with pegylated interferon and ribavirin removed all detectable viruses in 99 per cent of patients for up to seven years.

New Formulation Interferon Beta-1a Demonstrates Improved Safety ...  -  May 8, 2007
DG NewsTreatment with interferon beta in MS patients can be associated with the development of neutralising antibodies (NAbs), which have been shown to reduce the

Chevron units sells Dynegy stock worth $940 million  -  May 22, 2007
Contra Costa Times,Emeryville-based Intarcia Therapeutics Inc. presented results from a Phase 2 study showing that the combination of injectable omega interferon in

NEW JAB THAT CURES KILLER LIVER DISEASE  -  May 21, 2007
UK Express,Up until now, it was unclear whether or not an injection with a substance known as pegylated interferon would kill off the hepatitis C virus once and for

Viragen Increases Expression Levels of Interferon Alpha-2a Using ...  -  May 7, 2007
Genetic Engineering News (press release),Viragen reported that its researchers in Scotland and collaborators at Roslin Institute were able to significantly increase expression levels of interferon

Early Interferon Beta-1B Use in Multiple Sclerosis Patients Slows ...  -  May 2, 2007
DG NewsThese patients were treated with subcutaneous interferon beta-1b 250 mcg or placebo every other day until either a diagnosis of clinically definite MS was

In Brief  -  May 22, 2007
Alameda Times-Star,...omega interferon in combination with ribavirin shows promise in the management of hepatitis C, similar to the use of alpha interferon plus ribavirin.

Early Interferon Beta-1B (BetaseronR) In Multiple Sclerosis ...  -  May 1, 2007
Medical News Today,Prompt initiation of interferon beta-1b (BetaseronR) at the onset of suspected multiple sclerosis (MS) translates into less progression to chronic

Hepatitis C and its long-term effects are a growing problem  -  May 21, 2007
Gloucester Daily Times,..."We try to focus holistically on those undergoing interferon (immune stimulant) treatment because it is difficult," said executive director Susan Oleksiw.

Stanford researchers identify immune dysfunction in melanoma ...  -  May 11, 2007
exduco.net,Without the ability to respond to interferon, the cells are less able to fend off the cancer, according to the study that will be published in the May issue

Immune System Dysfunction Pinpointed in Melanoma Cases  -  May 14, 2007
Washington Post,These findings help explain why a common melanoma treatment involving prolonged exposure to interferon sometimes helps melanoma patients, said senior author

Multiferon(R) Shows Potent Activity in Preventing the Progression ...  -  May 9, 2007
PipelineReview.com (press release),Long-term treatment with Multiferon(R) was found to result in substantially fewer interferon-resistant melanoma clones than treatment with Intron(R) A. When

Could statins be a new option for hepatitis C patients?  -  May 21, 2007
SpiritIndia,Although there have been no new treatments for hepatitis C since the introduction of pegylated interferon in 2001, the opportunity to develop a new

Multiferon(R) Shows Potent Activity in Preventing the Progression ...  -  May 8, 2007
PR Newswire (press release),Results: Long-term treatment with Multiferon(R) was found to result in substantially fewer interferon-resistant melanoma clones than treatment with

Herpes Infection May Help To Fight Off Some Bacteria  -  May 22, 2007
Medical News Today (press release),..."We found evidence that the mouse immune system controls latent herpes infections in part by increasing production of a protein hormone called interferon

Hatching hep C hope  -  May 9, 2007
BiopharmaReporter.com,Interferon alpha-2a is commonly prescribed for the treatment of hepatitis C, and is the active ingredient in Roche's Roferon A product for treatment of

Amarillo Biosciences Issues Corporate Update on Influenza and ...  -  May 2, 2007
SYS-CON Media,Preliminary findings have shown that low-dose oral interferon provides a significant survival benefit against a fatal challenge of this virus.

OctoPlus broadens rights to PolyActive delivery technology  -  26 Apr 2007
BiopharmaReporter.com,The interferon-alfa is supplied by OctoPlus' US co-development partner Biolex Therapeutics. Outside that relationship, the Dutch company is exploring the

Product news in brief  -  26 Apr 2007
LabTechnologist.com,It can be used as a constituent in the fermentation to produce antibiotics, extra -cellular protein, vaccines, interferon and diphtheria toxoid as well as

New deals for ProBioGens cell engineering group  -  Apr 25, 2007
In-PharmaTechnologist.com,It also sells biosimilar versions of interferon alfa-2a and pegylated interferon alfa-2a., sold by Roche as Roferon-A and Pegasys, respectively.

Ghana: Neglect of Hepatitis C Leaves People With HIV Vulnerable  -  Apr 24, 2007
AllAfrica.com,Interferon injections are given weekly, in addition to ribavirin tablets. The tablets may be provided free for people paying for interferon injections.

Hemispherx and Armada Health Care enter Agreement to Launch ...  -  Apr 23, 2007
PipelineReview.com (press release),Alferon(R) is the only naturally derived alpha interferon approved in the United States. Studies have indicated Alferon(R) produces fewer adverse reactions

Intarcia Therapeutics announces results from study of injectable ...  -  Apr 15, 2007
News-Medical.net,Intarcia Therapeutics has announced final results from a Phase 2 study of omega interferon with or without ribavirin in treatment-naive patients with

Hemispherx Biopharma, Inc.  -  Apr 23, 2007
PharmaLive.com (press release),AlferonR is the only naturally derived alpha interferon approved in the United States. Studies have indicated AlferonR produces fewer adverse reactions than

Iranian researchers produce Pegilated Interferon medicine  -  Apr 15, 2007
Payvand,Tehran, April 14, IRNA - Minister of Health, Treatment and Medical Education announced on Saturday the production of Pegilated Interferon medicine by

Iranians produce Pegilated Interferon medicine  -  Apr 15, 2007
IranMania News,LONDON, April 15 (IranMania) - Iranian Minister of Health, Treatment and Medical Education announced the production of Pegilated Interferon medicine by

Vertex Vibrates Hepatitis Drug Sector  -  Apr 23, 2007
TheStreet.comVertex is using Roche's version of long-acting interferon alpha, called Pegasys, in all the clinical trials for Vertex's telaprevir hepatitis C drug.

Hemispherx and Armada Health Care enter Agreement to Launch ...  -  Apr 23, 2007
Genetic Engineering News (press release),Hemispherx Biopharma, Inc. (AMEX: HEB) announced today that they have enter into an agreement with Armada Health Care to launch their natural interferon,

Iranian researchers produce Pegilated Interferon medicine  -  Apr 14, 2007
IRNA,Minister of Health, Treatment and Medical Education announced on Saturday the production of Pegilated Interferon medicine by Iranian researchers.

TERMINAL CANCER PATIENT FORCED TO PAY £3200 A MONTH FOR 'WONDER-DRUG'  -  Apr 23, 2007
this is staffordshire,Interferon has a 10 to 15 per cent chance of working following surgery but Angelena is unable to have an operation. A North Staffordshire PCT spokesman

The Limits of a Promising Drug  -  Apr 22, 2007
Barron's (subscription)Vertex bulls have been hoping for success from just three months of treatment with Telapravir plus interferon plus ribavirin, followed by three months of

Biogen Idec (BIIB) Says AVONEX More Cost Effective to Other ...  -  Apr 13, 2007
StreetInsider.com (subscription),...(AMCP) 2007 Annual Meeting show that AVONEX is a cost-effective therapy in multiple sclerosis (MS) when compared to other interferon beta treatments.

MedImmune Expands Anti-Interferon-Alpha Program by Initiating ...  -  Apr 5, 2007
Drug Newswire (press release),Elevated type-1 interferon mRNA levels have been found in preclinical models of psoriasis, and inhibition of type 1 interferon in these models has been

HBP Helix pleased with phase II Tropical Interferon tests  -  Apr 2, 2007
Therapeutics Daily (subscription) (press release),Helix BioPharma Corp. is releasing results from its phase II clinical study of its Topical Interferon Alpha-2b in women with human papilloma virus induced

New One-Year Pharmacoeconomic Study Shows Avonex® Is Cost ...  -  Apr 18, 2007
Medical News Today (press release),The MS Benchmarks analysis showed the total costs over one-year to MS patients on interferon beta therapy were: AVONEX, $19896.15; Rebif® (Interferon

Viragen announces European Multiferon licensing agreement  -  Apr 22, 2007
News-Medical.net,In Multiferon(R), we are extremely excited about offering a safe, cost-effective, human interferon that can significantly reduce the risk of relapse and

Hemispherx in marketing deal for treatment  -  Apr 23, 2007
MSN MoneyAlferon, a natural interferon, has Food and Drug Administration approval as a treatment for human papilloma virus-related genital warts.

Intarcia Therapeutics Announces Final Results From a Phase 2 Study ...  -  Apr 13, 2007
Drug Newswire (press release),This Phase 2 study of daily subcutaneous omega interferon injections provides Intarcia with safety and clinical response data to support continued

Additional Preclinical Data Presented on Valopicitabine Combined ...  -  Apr 12, 2007
PipelineReview.com (press release),Pegylated interferon alfa and ribavirin therapy, the current standard of care, is successful in treating 42 - 46 percent of treatment-naive HCV genotype-1

MS Patients Not Receiving Medications To Slow Disease Progression ...  -  Apr 20, 2007
Medical News Today (press release),They are: interferon-1b (sold under the name Betaseron®), interferon-1a (Avonex®), glatiramer acetate (GA or Copaxone®), interferon-1a (Rebif®),

Dutton Associates Announces Investment Opinion: Amarillo ...  -  Apr 16, 2007
PharmaLive.com (press release),Amarillo Biosciences is a biopharmaceutical company developing low-dose oral natural human interferon-alpha as a safe, cost-effective therapy for several

New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective ...  -  Apr 13, 2007
PharmaLive.com (press release),The MS Benchmarks analysis showed the total costs over one-year to MS patients on interferon beta therapy were: AVONEX, $19896.15; Rebif(R) (Interferon

New One-Year Pharmacoeconomic Study Shows AVONEX ® is Cost ...  -  Apr 13, 2007
Business Wire (press release),The MS Benchmarks analysis showed the total costs over one-year to MS patients on interferon beta therapy were: AVONEX, $19896.15; Rebif ® (Interferon

Data Presented at AACR Meeting Shows Peregrine's Immunocytokine ...  -  Apr 18, 2007
PharmaLive.com (press release),In these proof of principle studies, VTA immunocytokines were created by combining type I interferon and interleukin 2 with 2aG4, an anti-phospholipid

EASL: Telaprevir Shows Promise of Shortened Hepatitis C Therapy  -  Apr 16, 2007
MedPage Today,Standard of care for hepatitis C virus is 48 weeks of pegylated interferon alfa-2a -- injected one a week, plus oral ribavirin twice a day for 48 weeks.

Idenix Pharma Reveal Results From 2 Phase IIb Studies Of ...  -  Apr 12, 2007
Trading Markets,According to the company, pegylated interferon alfa and ribavirin therapy, the current standard of care, is successful in treating 42 - 46 percent of

Analysis: Shorter therapy for hepatitis C?  -  Apr 16, 2007
Science Daily (press release)The current standard of care for hepatitis C virus infection is 48 weeks of interferon - a once-a-week injection, plus twice daily oral ribavirin.

Medical Edge: Benefits of hepatitis C drugs outweigh side effects  -  Apr 14, 2007
Bryan College Station Eagle,I have heard about interferon treatment with ribavirin, but am concerned about side effects. What other options may be available in the near future?

Peregrine's (PPHM) Immunocytokine Fusion Proteins Reduce Growth of ...  -  Apr 18, 2007
StreetInsider.com (subscription),The studies also showed that different forms of the VTAs could be combined, and that the combination of 2aG4-IL-2 with 2aG4-alpha interferon was

ViroPharma Announces Presentation of Additional HCV-796 Data at ...  -  Apr 14, 2007
PipelineReview.com (press release),These data on the antiviral activity and tolerability of twice daily HCV-796 in combination with pegylated interferon alfa-2b (peg-IFN) elaborate on

MS patients not receiving medications to slow disease progression  -  Apr 18, 2007
News-Medical.net,They are: interferon-1b (sold under the name Betaseron), interferon-1a (Avonex), glatiramer acetate (GA or Copaxone), interferon-1a (Rebif),

Idenix (IDIX) Reports Results from Two Phase IIb Studies of the ...  -  Apr 12, 2007
StreetInsider.com (subscription),At the end of the treatment period, which was 48 weeks, 53% of patients treated with 200 mg/day valopicitabine plus pegylated interferon achieved

Roche files Avastin for use in advanced renal cell cancer ...  -  Apr 19, 2007
Forbes,The filing is based on data from the pivotal phase III AVOREN study, which has shown Avastin in combination with interferon significantly prolongs

Roche files Avastin for advanced renal cell cancer  -  Apr 19, 2007
ReutersThe drug would be used in combination with interferon for the first line treatment of patients with advanced and/or metastatic renal cell cancer,

Helix BioPharma Corp. announces positive phase II clinical results ...  -  Apr 2, 2007
CNW Telbec (Communiqués de presse),...(TSX: HBP/Frankfurt: WKN 918864) Helix today announced positive results from its phase II clinical study of its Topical Interferon Alpha-2b in women with

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional